Statement of Changes in Beneficial Ownership (4)
11 August 2021 - 11:18PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Yrigoyen Dan |
2. Issuer Name and Ticker or Trading Symbol
Arch Therapeutics, Inc.
[
ARTH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Vice President, Sales |
(Last)
(First)
(Middle)
C/O ARCH THERAPEUTICS, INC., 235 WALNUT STREET, SUITE 6 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/30/2021 |
(Street)
FRAMINGHAM, MA 01702
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock (1) | 7/30/2021 | | A | | 150000 | A | $0 | 150000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (right to buy) | $0.09 | 7/30/2021 | | A | | 150000 | | (2) | 7/29/2031 | Common Stock | 150000 | $0 | 150000 | D | |
Explanation of Responses: |
(1) | 1/3 of the Shares (50,000) shall vest on each of the six (6), twelve (12) and eighteen month anniversaries of 7/12/2021, the vesting commencement date. |
(2) | The Shares subject to the Option, 1/3 (50,000) shall vest on the anniversary of the vesting commencement date (7/12/21), and 1/24 of the remaining shares shall vest on each of the next twenty-four monthly anniversaries 7/12/2022, subject to continued service to the Company through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), then, in any such case, 100% of the number of unvested shares then subject to the option and then subject to any other then-outstanding stock option or other equity award that may have been granted under or outside of the Plan shall accelerate and become vested as of the date of such event. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Yrigoyen Dan C/O ARCH THERAPEUTICS, INC. 235 WALNUT STREET, SUITE 6 FRAMINGHAM, MA 01702 |
|
| Vice President, Sales |
|
Signatures
|
/s/ Dan Yrigoyen | | 8/11/2021 |
**Signature of Reporting Person | Date |
Arch Therapeutics (QB) (USOTC:ARTH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Arch Therapeutics (QB) (USOTC:ARTH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Arch Therapeutics Inc (QB) (OTCMarkets): 0 Nachrichtenartikel
Weitere Arch Therapeutics, Inc. News-Artikel